文献速递细菌感染、耐药与抗菌药物医院感染防控

抗菌药物管理干预研究质量的系统综述

The quality of studies evaluating antimicrobial stewardship interventions: a systematic review.
PubMed 文献 · Clin Microbiol Infect · 2018-11-23

该研究系统检索PubMed 1950年1月至2017年1月发表的抗菌药物管理干预研究,纳入825篇文献,评估其设计质量。结果显示多数研究为非实验性设计,社区研究质量优于医院研究,且报告临床与微生物学结局的比例偏低,整体质量未见随时间改善。

要点

  • 多数抗菌药物管理研究为非实验性设计,整体方法学质量偏低。
  • 仅48%报告临床结局、23%报告微生物学结局,证据基础受限。
  • 社区研究更常采用随机化、外部对照和多中心设计。

核心结论

  • 抗菌药物管理研究的整体质量偏低且未随时间改善,多数未报告临床和微生物学结局数据,社区研究质量相对较好。

研究设计与样本

  • 系统综述,检索PubMed 1950年1月至2017年1月发表的任何抗菌药物管理干预研究,不限设计和结局,共纳入825篇。

主要发现

  • 675/825(82%)为非实验性研究,104篇(15%)使用中断时间序列分析,41篇(6%)使用外部对照,19篇(3%)两者兼用。
  • 社区研究满足10项质量特征的中位数为5项(IQR 3-7),医院研究为3项(IQR 2-4)。
  • 社区研究(25%,205/825)更可能采用随机化(OR 5.9;95%CI 3.8-9.2)、外部对照(OR 5.6;95%CI 3.6-8.5)和多中心(OR 10.5;95%CI 7.1-15.7)。
  • 仅48%(398/825)报告临床结局,23%(190/825)报告微生物学结局,质量未随时间改善。

临床怎么用

  • 解读抗菌药物管理干预证据时需注意其设计局限,未来评估应优先采用稳健设计并报告临床与微生物学结局。

局限性

  • 仅检索PubMed单一数据库,纳入研究时间截至2017年1月,未涉及后续发表的研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antimicrobial stewardship aims to optimize antibiotic use and minimize selection of antimicrobial resistance. The methodological quality of published studies in this field is unknown. AIMS: Our objective was to perform a comprehensive systematic review of antimicrobial stewardship research design and identify features which limit validity and translation of research findings into clinical practice. SOURCES: The following online database was searched: PubMed. STUDY ELIGIBILITY CRITERIA: Studies published between January 1950 and January 2017, evaluating any antimicrobial stewardship intervention in the community or hospital setting, without restriction on study design or outcome. CONTENT: We extracted data on pre-specified design quality features and factors that may influence design choices including (1) clinical setting, (2) age group studied, (3) when the study was conducted, (4) geographical region, and (5) financial support received. The initial search yielded 17 382 articles; 1008 were selected for full-text screening, of which 825 were included. Most studies (675/825, 82%) were non-experimental; 104 (15%) used interrupted time series analysis, 41 (6%) used external controls, and 19 (3%) used both. Studies in the community setting fulfilled a median of five out of 10 quality features (IQR 3-7) and 3 (IQR 2-4) in the hospital setting. Community setting studies (25%, 205/825) were significantly more likely to use randomization (OR 5.9; 95% CI 3.8-9.2), external controls (OR 5.6; 95% CI 3.6-8.5), and multiple centres (OR 10.5; 95% CI 7.1-15.7). From all studies, only 48% (398/825) reported clinical and 23% (190/825) reported microbiological outcomes. Quality did not improve over time. IMPLICATIONS: Overall quality of antimicrobial stewardship studies is low and has not improved over time. Most studies do not report clinical and microbiological outcome data. Studies conducted in the community setting were associated with better quality. These limitations should inform the design of future stewardship evaluations so that a robust evidence base can be built to guide clinical practice.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Schweitzer VA, van Heijl I, van Werkhoven CH, et al. The quality of studies evaluating antimicrobial stewardship interventions: a systematic review. Clin Microbiol Infect. 2018. PMID: 30472426. doi:10.1016/j.cmi.2018.11.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。